Bahrain vs Moldova: Cause of death, by non-communicable diseases, ages 15-59
Bahrain
57.7%
in 2021
Moldova
58.9%
in 2021
Bahrain rank
81st
Moldova rank
78th
Cause of death, by non-communicable diseases, ages 15-59 over time
- Bahrain
- Moldova
How they compare
Moldova currently reports 58.9% against 57.7% in Bahrain, a difference of 1.2%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Moldova ahead.
Bahrain ranks 81st and Moldova ranks 78th of 185 countries.
Across the 3 decades both report, Bahrain averaged higher in 1 and Moldova in 2.
Head to head by decade
| Decade | Bahrain | Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 60.3% | 70.8% | 10.5% | Moldova |
| 2010s | 74.6% | 72.0% | 2.7% | Bahrain |
| 2020s | 61.5% | 61.7% | 0.2% | Moldova |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Bahrain or Moldova?
- Moldova, at 58.9% against 57.7% in Bahrain as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Bahrain and Moldova?
- 1.2%, with Moldova ahead.
- How many years of comparable data are there for Bahrain and Moldova?
- 6 years are reported by both, from 2000 to 2021.
- How do Bahrain and Moldova rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Bahrain ranks 81st and Moldova ranks 78th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.